{"id":"W3026305773","doi":"10.26508/lsa.201900562","title":"Tradeoff between metabolic i-proteasome addiction and immune evasion in triple-negative breast cancer","year":2020,"lang":"en","type":"article","venue":"Life Science Alliance","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"BC Cancer Agency; Medical Research Council; National Health and Medical Research Council; Cancer Research UK; QIMR Berghofer Medical Research Institute","keywords":"Carfilzomib; Triple-negative breast cancer; Proteasome; Cancer research; Breast cancer; Bortezomib; Biology; Immune system; Proteasome inhibitor; Adjuvant; Immunology; Cancer; Multiple myeloma; Medicine; Internal medicine; Cell biology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002013565,0.0001706375,0.000196142,0.0001864395,0.0001476196,0.0004191963,0.0001019811,0.0001621084,0.0009744373],"category_scores_gemma":[0.0001524555,0.00009155885,0.0001220471,0.0001418093,0.0001775227,0.0001875058,0.0001822225,0.0003180493,0.0001451327],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004356339,"about_ca_system_score_gemma":0.0002123544,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005079454,"about_ca_topic_score_gemma":0.0008723459,"domain_scores_codex":[0.9999163,0.00001631595,0.000004664892,0.00001603409,0.00001798813,0.0000286437],"domain_scores_gemma":[0.9999366,0.000005776245,0.00002453555,0.000003064682,0.000004729271,0.00002526343],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001972612,0.0001394657,0.02637256,0.0001253057,0.00004509724,0.0003666861,0.00007430252,0.0003607999,0.9452974,0.0008543544,0.000471387,0.02392001],"study_design_scores_gemma":[0.0001897396,0.004288394,0.4635735,0.00006547956,0.0001692265,0.005241118,0.0009115015,0.00430507,0.5046858,0.002808466,0.01373119,0.00003058607],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949239,0.003372652,0.000344853,0.0002325854,0.00001064791,0.000004641822,0.00005676738,0.00001362178,0.001040389],"genre_scores_gemma":[0.9985389,0.0008271488,0.0001398585,0.00004665755,0.000004875117,0.000004103561,0.0000400005,0.000001537873,0.0003969775],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009744373,"threshold_uncertainty_score":0.003259838,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02631901313016773,"score_gpt":0.2751828358517443,"score_spread":0.2488638227215766,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}